125 related articles for article (PubMed ID: 25390066)
1. Pseudomonas aeruginosa infection in burn patients in Sulaimaniyah, Iraq: risk factors and antibiotic resistance rates.
Othman N; Babakir-Mina M; Noori CK; Rashid PY
J Infect Dev Ctries; 2014 Nov; 8(11):1498-502. PubMed ID: 25390066
[No Abstract] [Full Text] [Related]
2. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas infections in Tohid Burn Center, Iran.
Rastegar Lari A; Bahrami Honar H; Alaghehbandan R
Burns; 1998 Nov; 24(7):637-41. PubMed ID: 9882062
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
Mikura S; Wada H; Okazaki M; Nakamura M; Honda K; Yasutake T; Higaki M; Ishii H; Watanabe T; Tsunoda T; Goto H
J Hosp Infect; 2011 Nov; 79(3):267-8. PubMed ID: 21864937
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
Ullah F; Malik SA; Ahmed J
Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia.
Djordjevic Z; Folic M; Ruzic Zecevic D; Ilic G; Jankovic S
J Infect Dev Ctries; 2013 Sep; 7(9):686-90. PubMed ID: 24042106
[No Abstract] [Full Text] [Related]
8. Prevalence, antimicrobial susceptibility, and genetic diversity of Pseudomonas aeruginosa as intestinal colonizer in the community.
Valenza G; Tuschak C; Nickel S; Krupa E; Lehner-Reindl V; Höller C
Infect Dis (Lond); 2015 Sep; 47(9):654-7. PubMed ID: 25832457
[TBL] [Abstract][Full Text] [Related]
9. Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program.
Morrow BJ; Pillar CM; Deane J; Sahm DF; Lynch AS; Flamm RK; Peterson J; Davies TA
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):412-6. PubMed ID: 23391609
[TBL] [Abstract][Full Text] [Related]
10. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
Arya SC; Agarwal N; Agarwal S
Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
[No Abstract] [Full Text] [Related]
11. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of Pseudomonas aeruginosa in a burn unit.
Pednekar SN; Dohe VB; Deshpande SM; Kamble SS; Bharadwaj RS; Shouche YS
Burns; 2010 Nov; 36(7):e130-1. PubMed ID: 20883907
[No Abstract] [Full Text] [Related]
13. [Survey on the bacterial flora and their resistance to antibiotics in hospitalized burn patients on tropical islands].
Liang ZH; Pan YC; Chen SH; Xu JQ; Chen Y
Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):88-90. PubMed ID: 17649878
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
[TBL] [Abstract][Full Text] [Related]
15. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran.
Khosravi AD; Mihani F
Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Coetzee E; Rode H; Kahn D
S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological tracing of Pseudomonas aeruginosa: antibiogram and serotyping.
Dayton SL; Blasi D; Chipps DD; Smith RF
Appl Microbiol; 1974 Jun; 27(6):1167-9. PubMed ID: 4208641
[TBL] [Abstract][Full Text] [Related]
18. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
Ziółkowski G; Dudzińska G; Sakiel S
Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
[No Abstract] [Full Text] [Related]
19. First prevalence survey of surgical site infections in the University Hospital Centre 'Mother Teresa' of Tirana.
Faria S; Dauri M; Schinaia N; Gjata A; Sabato AF; Bilaj A; Llazo E; Mertiraj O; Sodano L;
J Hosp Infect; 2008 Dec; 70(4):381-3. PubMed ID: 18848737
[No Abstract] [Full Text] [Related]
20. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria.
Takesue Y; Nakajima K; Ichiki K; Ishihara M; Wada Y; Takahashi Y; Tsuchida T; Ikeuchi H
J Hosp Infect; 2010 May; 75(1):28-32. PubMed ID: 20346536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
